Skip to content

Efficacy and safety of Clidinium bromide and Chlordiazepoxide hydrochloride combination as add-on therapy in functional dyspepsia

Efficacy and safety of Clidinium bromide and Chlordiazepoxide hydrochloride combination as add-on therapy in functional dyspepsia

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20171016004
Enrollment
88
Registered
2017-10-16
Start date
2017-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia Functional dyspepsia Clidinium bromide Chlordiazepoxide hydrochloride

Interventions

1 capsule consist of of Clidinium bromide 2.5 mg and Chlordiazepoxide hydrochloride 5 mg. Take 1 capsule 3 times/day before meal &#44
for 4 weeks,Take 1 placebo capsule 3 times/day before meal &#44
for 4 weeks
Experimental Drug,Placebo Comparator Drug
Clidinium bromide and Chlordiazepoxide hydrochloride combination,Placebo

Sponsors

The Gastroenterological Association of Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients age 18-70 years Diagnosed functional dyspepsia according to Rome IV criteria Normal upper endoscopy within 1 year No evidence of Helicobacter pylori infection Partial or non-rensponder to proton pump inhibitor standard treatment

Exclusion criteria

Exclusion criteria: History of irritable bowel syndrome Major physical illness Current active alcohol abuse History of obstructive uropathy Pregnancy and Lactation History of allergy to benzodiazepine, proton pump inhibitor, antispasmodic and anticholinergic drug.

Design outcomes

Primary

MeasureTime frame
Global overall symptom scale Day 0 (at baseline), End of week 1, End of week 2, End of week 3 , End of week 4 score

Secondary

MeasureTime frame
Short form Nepean dyspepsia index Day 0 (at baseline), End of week 4 score

Countries

Thailand

Contacts

Public ContactSiripa Puasripun

Department of Internal Medicine, Faculty of medicine, Chiang Mai university

siripapuasripun@gmail.com0882683435

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026